刺突蛋白抗体介导了SARS-CoV-2核衣壳抗体与中和试验结果之间的明显相关性。 - Suppr

Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results.

作者信息

Perkmann Thomas, Koller Thomas, Perkmann-Nagele Nicole, Klausberger Miriam, Duerkop Mark, Holzer Barbara, Hartmann Boris, Mucher Patrick, Radakovics Astrid, Ozsvar-Kozma Maria, Wagner Oswald F, Binder Christoph J, Haslacher Helmuth

机构信息

Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

Institute of Molecular Biotechnology, Department of Biotechnology, University of Natural Resources and Life Sciences (BOKU) Vienna, Vienna, Austria.

出版信息

Microbiol Spectr. 2021 Sep 3;9(1):e0021821. doi: 10.1128/Spectrum.00218-21. Epub 2021 Jun 16.

DOI:10.1128/Spectrum.00218-21

PMID:34132615

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8552595/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b3c/8552595/6ed2ae7fa836/spectrum.00218-21-f001.jpg

相似文献

Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results.

Microbiol Spectr. 2021 Sep 3;9(1):e0021821. doi: 10.1128/Spectrum.00218-21. Epub 2021 Jun 16.

SARS-CoV-2 antibodies: Comparison of three high-throughput immunoassays versus the neutralization test.

Eur J Clin Invest. 2021 Jul;51(7):e13573. doi: 10.1111/eci.13573. Epub 2021 May 5.

Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection.

Front Immunol. 2021 Nov 26;12:793953. doi: 10.3389/fimmu.2021.793953. eCollection 2021.

Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients.

mSphere. 2021 Feb 24;6(1):e01145-20. doi: 10.1128/mSphere.01145-20.

SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.

J Infect Dis. 2021 Apr 8;223(7):1120-1131. doi: 10.1093/infdis/jiaa797.

Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring.

Clin Immunol. 2022 Jan;234:108918. doi: 10.1016/j.clim.2021.108918. Epub 2021 Dec 29.

Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein.

Virol J. 2021 Jan 12;18(1):16. doi: 10.1186/s12985-021-01490-7.

Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients.

J Infect Dis. 2021 Feb 13;223(3):389-398. doi: 10.1093/infdis/jiaa659.

The complexities of SARS-CoV-2 serology.

Lancet Infect Dis. 2020 Dec;20(12):1350-1351. doi: 10.1016/S1473-3099(20)30699-X. Epub 2020 Sep 23.

Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays.

Clin Chem. 2020 Dec 1;66(12):1538-1547. doi: 10.1093/clinchem/hvaa211.

引用本文的文献

The Luciferase Immunoprecipitation System (LIPS) Targeting the Spike Protein of SARS-CoV-2 Is More Accurate than Nucleoprotein-Based LIPS and ELISAs for Mink Serology.

Transbound Emerg Dis. 2023 Feb 22;2023:1318901. doi: 10.1155/2023/1318901. eCollection 2023.

Sequence Matters: Primary COVID-19 Vaccination after Infection Elicits Similar Anti-spike Antibody Levels, but Stronger Antibody Dependent Cell-mediated Cytotoxicity than Breakthrough Infection.

J Immunol. 2024 Oct 15;213(8):1105-1114. doi: 10.4049/jimmunol.2400250.

Importance, Applications and Features of Assays Measuring SARS-CoV-2 Neutralizing Antibodies.

Int J Mol Sci. 2023 Mar 10;24(6):5352. doi: 10.3390/ijms24065352.

Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.

Elife. 2023 Jan 24;12:e80428. doi: 10.7554/eLife.80428.

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan.

Front Immunol. 2022 Nov 15;13:1023943. doi: 10.3389/fimmu.2022.1023943. eCollection 2022.

Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technology.

J Mol Cell Biol. 2022 Aug 17;14(4). doi: 10.1093/jmcb/mjac023.

Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021.

Euro Surveill. 2022 Jan;27(1). doi: 10.2807/1560-7917.ES.2022.27.1.2101114.

Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England.

Nat Commun. 2021 Dec 10;12(1):7217. doi: 10.1038/s41467-021-27410-5.

Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers.

Vaccines (Basel). 2021 Sep 28;9(10):1092. doi: 10.3390/vaccines9101092.

Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222.

Int J Infect Dis. 2021 Sep;110:309-313. doi: 10.1016/j.ijid.2021.07.063. Epub 2021 Jul 28.

本文引用的文献

A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests.

EBioMedicine. 2021 May;67:103348. doi: 10.1016/j.ebiom.2021.103348. Epub 2021 Apr 25.

Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.

J Clin Microbiol. 2021 Apr 20;59(5). doi: 10.1128/JCM.02890-20.

Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test.

Clin Chem. 2021 Apr 29;67(5):742-752. doi: 10.1093/clinchem/hvaa336.

Multicenter Evaluation of the Clinical Performance and the Neutralizing Antibody Activity Prediction Properties of 10 High-Throughput Serological Assays Used in Clinical Laboratories.

J Clin Microbiol. 2021 Feb 18;59(3). doi: 10.1128/JCM.02511-20.

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals.

Front Microbiol. 2020 Oct 19;11:584251. doi: 10.3389/fmicb.2020.584251. eCollection 2020.

Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions.

Trends Immunol. 2020 Nov;41(11):1006-1022. doi: 10.1016/j.it.2020.09.004. Epub 2020 Sep 17.

Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays.

Clin Chem. 2020 Dec 1;66(12):1538-1547. doi: 10.1093/clinchem/hvaa211.

Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.

JCI Insight. 2020 Sep 17;5(18):142386. doi: 10.1172/jci.insight.142386.

Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity.

Clin Chem. 2020 Nov 1;66(11):1405-1413. doi: 10.1093/clinchem/hvaa198.

Usage Data and Scientific Impact of the Prospectively Established Fluid Bioresources at the Hospital-Based MedUni Wien Biobank.

Biopreserv Biobank. 2018 Dec;16(6):477-482. doi: 10.1089/bio.2018.0032. Epub 2018 Oct 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献